Orphenadrine |
Norflex |
Article: Orphenadrine
| Image:Orphenadrine.png | |
| Orphenadrine | |
| Systematic (IUPAC) name | |
| N,N-dimethyl-2-[(2-methylphenyl) -phenyl-methoxy]-ethanamine | |
| Identifiers | |
| CAS number | 83-98-7 |
| ATC code | M03BC01 N04AB02 |
| PubChem | 4601 |
| DrugBank | APRD00097 |
| Chemical data | |
| Formula | C18H23NO |
| Mol. weight | 269.381 g/mol |
| Pharmacokinetic data | |
| Bioavailability | 90% |
| Protein binding | 95% |
| Metabolism | Hepatic |
| Half life | 13-20 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | Oral, intravenous, intramuscular |
Orphenadrine (Norflex®) is a drug used to treat muscle injuries and Parkinson's disease.
Resources
- Norflex (Drug Digest)
- Orphenadrine (Drug Digest)

Not Signed In -

